Competition Between Plasminogen and Tissue Plasminogen Activator for Cellular Binding Sites
Cellular receptors for plasminogen and tissue plasminogen activator (t-PA) regulate plasminogen activation and cell-associated proteolytic activity. The characteristics of the interactions of both ligands with monocytes and monocyt-oid cell lines bear certain similarities, including affinity (kd app...
Saved in:
Published in | Blood Vol. 82; no. 8; pp. 2433 - 2441 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
Elsevier Inc
15.10.1993
The Americain Society of Hematology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cellular receptors for plasminogen and tissue plasminogen activator (t-PA) regulate plasminogen activation and cell-associated proteolytic activity. The characteristics of the interactions of both ligands with monocytes and monocyt-oid cell lines bear certain similarities, including affinity (kd approximately 1 μmol/L) capacity and susceptibility to car-boxypeptidase treatment. Therefore, we have undertaken the present study to determine directly whether t-PA and plasminogen share common binding sites on cells. We found that recombinant human single-chain t-PA (rt-PA) could inhibit the binding of 125l-plasminogen to the cells and, conversely, plasminogen could inhibit 125l-rt-PA binding. This relationship was observed with 9 cell types, including both adherent cells and cells in suspension. In addition, under several conditions of cell treatment, plasminogen and t-PA receptor expression was modulated in parallel. Furthermore, molecules that have been implicated as candidate plasminogen receptors, gangliosides, and an α-enolase—related molecule, also interacted with t-PA. These results suggest that at least a component of the binding sites for plasminogen is shared with t-PA. Occupancy of these sites by either or both ligand(s) should result in arming the cells with the proteolytic activity of plasmin. |
---|---|
ISSN: | 0006-4971 1528-0020 |
DOI: | 10.1182/blood.V82.8.2433.2433 |